| 中文別名： |
甲基氫化潑尼松;甲基強的松龍;甲基潑尼松龍;甲潑尼龍;甲強龍;6α-甲基強的松龍;六甲基潑尼松龍;皮質(zhì)[甾]酮;6a甲基潑尼松龍;6-A-甲基潑尼松龍;6a-甲基潑尼松龍;6-α-甲基潑尼松標(biāo)準(zhǔn)品;6α-甲基潑尼松龍;6-α-甲基潑尼松龍-D4;甲醇中甲基潑尼松龍溶液標(biāo)準(zhǔn)物質(zhì);甲基潑尼松龍 標(biāo)準(zhǔn)品;甲基潑尼松龍(6α-甲基潑尼松龍);甲基潑尼松龍標(biāo)準(zhǔn)溶液;甲基強的松龍,USP,BP,EP;甲基強的松龍標(biāo)準(zhǔn)品;甲基氫化潑尼松原藥;甲潑尼龍 USP標(biāo)準(zhǔn)品;炔雌醇中間體;11β,17α,21-三羥基-6α-甲基-1,4-孕甾二烯-3,20-二酮;11β,17α,21-三羥基-6α-甲基-1,4-孕甾二烯-3,20-二酮 6α-甲基-11β,17α,21-三羥基-1,4-孕甾二烯-3,20-二酮 6α-甲基潑尼松龍 甲基強的松龍 甲基潑尼松龍;6α-甲基-11β,17α,21-三羥基-1,4-孕甾二烯-3,20-二酮;甲基潑尼松龍醋酸酯雜質(zhì)B(EP);甲基潑尼松龍琥珀酸鈉雜質(zhì)A(EP) 標(biāo)準(zhǔn)品;甲潑尼龍雜質(zhì)B;甲潑尼龍系統(tǒng)適用性;甲潑尼松龍;琥珀酸甲潑尼龍A |
| 英文別名： |
6alpha-methylprednisolone;Methylprednisolone;11-beta,17-alpha,21-trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione;6-methyl prednisolone acetate;6-α-Methylprednisolone;(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one;6α-Methyl Prednisolo;6α-Methyl Prednisolone;6-α-Methylprednisolone Solution;Methylprednisolone & Salts;METHYLPREDNISOLONE, USP;Metilprednisolone;U 7532;11β,17α,21-Trihydroxy-6α-methyl-1,4-pregnadiene-3,20-dione;11b,17a,21-Trihydroxy-6a-methyl-1,4-pregnene-3,20-dione;6alpha-Methyl-1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione;Medrol;Medrone;Urbason;Metilbetasone;Medrate;Dopomedrol;Promacortine;Wyacort;Urbasone;Metrisone;Medesone;Besonia;Metastab;Mesopren;Solomet;Noretona;Moderin;Methylprednisolon;Metrocort;Methyleneprednisolone;Suprametil;Sieropresol;Metysolon;Esametone;Reactenol;Firmacort;Medixon;Nirypan;Lemod;Artisone-wyeth;Medrol dosepak;6-alpha-Methylprednisolone;Medrol adt pak;Predni N Tablinen;Medlone 21;Metilprednisolone [DCIT];Summicort;;M;11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione;Prednol-L;6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione;HMS2230D16;SPBio_002377;SR-01000003089-2;MEPRDL;METHYLPREDNISOLONE HYDROGEN SUCCINATE IMPURITY A [EP IMPURITY];METHYLPREDNISOLONE [GREEN BOOK];SCHEMBL5084;HSDB 3127;METHYLPREDNISOLONE (MART.);Methylprednisolone, British Pharmacopoeia (BP) Reference Standard;Prednisolone, 6.alpha.-methyl-;Medrol (TN);BRN 2340300;Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6alpha,11beta)-;11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione;methylprenisolone;Prednisolone, 6alpha-methyl-;DTXCID903300;NSC19987;METHYLPREDNISOLONE [EP MONOGRAPH];NSC-19987;Metilprednisolona [INN-Spanish];NC00691;MLS002207191;METHYLPREDNISOLONE [HSDB];Tox21_110376;Methylprednisolone, Pharmaceutical Secondary Standard; Certified Reference Material;Veriderm Medrol;HMS2090B13;Methylprednisolonum [INN-Latin];BRD-K35240538-001-03-1;83-43-2;METHYLPREDNISOLONE [INN];Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-,(6.alpha.,11.beta.)-;METHYLPREDNISOLONE [ORANGE BOOK];6-methyl-prednisolone;Prestwick3_000279;EC 201-476-4;Solu-Medrol (sodium succinate);NCI60_001657;EINECS 201-476-4;GTPL7088;METHYLPREDNISOLONE [JAN];AKOS015969744;NCGC00016330-01;1,4-pregnadien-6alpha-methyl-11beta, 17, 21-triol-3, 20-dione;6alpha-Methylprednisolone base;Solpredone;(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione;Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-;SR-01000003089;Prestwick2_000279;6.alpha.-Methylprednisolone;1-dehydro-6-alpha-methylhydrocortisone;11?,17?,21-Trihydroxy-6?-methyl-1,4-pregnadiene-3,20-dione;Pregna-1,4-dieno-3,20-diona, 11,17,21-trihidroxi-6-metil-, (6alfa, 11beta)-;methylprednisolone;Summicort... |
滬公網(wǎng)安備31011402010658號 
